» Articles » PMID: 29617460

Loss of HAI-2 in Mice with Decreased Prostasin Activity Leads to an Early-onset Intestinal Failure Resembling Congenital Tufting Enteropathy

Overview
Journal PLoS One
Date 2018 Apr 5
PMID 29617460
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Prostasin (CAP1/PRSS8) is a glycosylphosphatidylinositol (GPI)-anchored serine protease that is essential for epithelial development and overall survival in mice. Prostasin is regulated primarily by the transmembrane serine protease inhibitor, hepatocyte growth factor activator inhibitor (HAI)-2, and loss of HAI-2 function leads to early embryonic lethality in mice due to an unregulated prostasin activity. We have recently reported that critical in vivo functions of prostasin can be performed by proteolytically-inactive or zymogen-locked variants of the protease. Here we show that the zymogen form of prostasin does not bind to HAI-2 and, as a result, loss of HAI-2 does not affect prenatal development and survival of mice expressing only zymogen-locked variant of prostasin (Prss8 R44Q). Indeed, HAI-2-deficient mice homozygous for R44Q mutation (Spint2-/-;Prss8R44Q/R44Q) are born in the expected numbers and do not exhibit any obvious developmental abnormality at birth. However, postnatal growth in these mice is severely impaired and they all die within 4 to 7 days after birth due to a critical failure in the development of small and large intestines, characterized by a widespread villous atrophy, tufted villi, near-complete loss of mucin-producing goblet cells, loss of colonic crypt structure, and bleeding into the intestinal lumen. Intestines of Spint2-/-;Prss8R44Q/R44Q mice showed altered expression of epithelial junctional proteins, including reduced levels of EpCAM, E-cadherin, occludin, claudin-1 and -7, as well as an increased level of claudin-4, indicating that the loss of HAI-2 compromises intestinal epithelial barrier function. Our data indicate that the loss of HAI-2 in Prss8R44Q/R44Q mice leads to development of progressive intestinal failure that at both histological and molecular level bears a striking resemblance to human congenital tufting enteropathy, and may provide important clues for understanding and treating this debilitating human disease.

Citing Articles

SPINT2 mutations in the Kunitz domain 2 found in SCSD patients inactivate HAI-2 as prostasin inhibitor via abnormal protein folding and N-glycosylation.

Huang N, Wang Q, Bernard R, Chen C, Hu J, Wang J Hum Mol Genet. 2024; 33(9):752-767.

PMID: 38271183 PMC: 11031362. DOI: 10.1093/hmg/ddae005.


Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.

Szabo R, Kawaguchi M, Kataoka H, Bugge T Development. 2023; 150(17).

PMID: 37539662 PMC: 10482385. DOI: 10.1242/dev.201801.


N-glycosylation on Asn-57 is required for the correct HAI-2 protein folding and protease inhibitory activity.

Huang N, Wang Q, Chen C, Hu J, Wang J, Chang P Glycobiology. 2023; 33(3):203-214.

PMID: 36637420 PMC: 10114645. DOI: 10.1093/glycob/cwad002.


Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.

Barndt R, Lee M, Huang N, Lu D, Lee S, Du P Hum Mol Genet. 2021; 30(19):1833-1850.

PMID: 34089062 PMC: 8444455. DOI: 10.1093/hmg/ddab150.


The Kunitz-type serine protease inhibitor Spint2 is required for cellular cohesion, coordinated cell migration and cell survival during zebrafish hatching gland development.

Hatzold J, Wessendorf H, Pogoda H, Bloch W, Hammerschmidt M Dev Biol. 2021; 476:148-170.

PMID: 33826923 PMC: 8820232. DOI: 10.1016/j.ydbio.2021.03.017.


References
1.
Leyvraz C, Charles R, Rubera I, Guitard M, Rotman S, Breiden B . The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol. 2005; 170(3):487-96. PMC: 2171460. DOI: 10.1083/jcb.200501038. View

2.
Szabo R, Sales K, Kosa P, Shylo N, Godiksen S, Hansen K . Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet. 2012; 8(8):e1002937. PMC: 3431340. DOI: 10.1371/journal.pgen.1002937. View

3.
Oshima T, Miwa H . Gastrointestinal mucosal barrier function and diseases. J Gastroenterol. 2016; 51(8):768-78. DOI: 10.1007/s00535-016-1207-z. View

4.
Friis S, Sales K, Schafer J, Vogel L, Kataoka H, Bugge T . The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. J Biol Chem. 2014; 289(32):22319-32. PMC: 4139241. DOI: 10.1074/jbc.M114.574400. View

5.
Szabo R, Hobson J, List K, Molinolo A, Lin C, Bugge T . Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem. 2008; 283(43):29495-504. PMC: 2570866. DOI: 10.1074/jbc.M801970200. View